Cargando…
Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management
Circulating tumoral DNA (ctDNA), commonly named “liquid biopsy”, has emerged as a new promising noninvasive tool to detect biomarker in several cancers including lung cancer. Applications involving molecular analysis of ctDNA in lung cancer have increased and encompass diagnosis, response to treatme...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343800/ https://www.ncbi.nlm.nih.gov/pubmed/28146051 http://dx.doi.org/10.3390/ijms18020264 |